InterCure Ltd. (INCR)

IL — Healthcare Sector
Peers: AYRWF  VRNOF  TLLTF  LOWLF  VEXTF  SSIC  COLL  PAHC  EGRX  RGC  DLTNF  RAMMF  CVGRF  BHHKF  SPBBF  PBH  PCRX  IXHL 

Automate Your Wheel Strategy on INCR

With Tiblio's Option Bot, you can configure your own wheel strategy including INCR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol INCR
  • Rev/Share 4.1703
  • Book/Share 8.3253
  • PB 0.6553
  • Debt/Equity 0.5325
  • CurrentRatio 1.7279
  • ROIC -0.0295

 

  • MktCap 256842626.0692
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE -8.1051
  • Debt/Assets 0.2772
  • DivYield 0
  • ROE -0.0724

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About InterCure Ltd. (INCR)

  • IPO Date 2019-01-28
  • Website https://www.intercure.co
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Mr. Alexander Rabinovich
  • Employees 320
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.